Extended interval between enzyme therapy infusions for adult patients with Gaucher's disease type 1.
J Postgrad Med
;
2003 Apr-Jun; 49(2): 127-31
Artigo
em Inglês
| IMSEAR
| ID: sea-115934
ABSTRACT
BACKGROUND:
Enzyme replacement therapy (ERT) for Gaucher's disease with alglucerase or imiglucerase is efficacious, well-tolerated and safe. However, cost considerations, visits to medical facilities, potentially duration of theray for life, are issues of major concern to a proportion of treated patients and has, in some cases, led to the withdrawal of therapy.AIMS:
To elucidate whether an extension of the interval between enzyme infusions to once every three weeks is as effective in maintaining the clinical responses achieved with the bi-monthly regimen. MATERIALS ANDMETHODS:
Four patients with an optimal response to ERT (at 30 units/kg every two weeks for an average of 27 months), were subjected to enzyme dose/frequency changes that essentially constituted a reduction in cumulative dose over the treatment period. Patients were assessed every 6 months for alterations in haematological parameters, plasma chitotriosidase levels, liver and spleen size, and bone symptoms.RESULTS:
All patients had to resume the previous infusion schedule of once every two weeks; one because of new bone marrow infiltrates, two because of visceral enlargement, and the fourth due to progressive anaemia.CONCLUSIONS:
This limited experience suggests that a reduction in enzyme dose associated with an extended interval between infusions may lead to variable disease control, and underscores the need for individualization of enzyme therapy.
Texto completo:
DisponíveL
Índice:
IMSEAR (Sudeste Asiático)
Assunto principal:
Fatores de Tempo
/
Infusões Intravenosas
/
Feminino
/
Humanos
/
Masculino
/
Esquema de Medicação
/
Criança
/
Adolescente
/
Adulto
/
Relação Dose-Resposta a Droga
Idioma:
Inglês
Revista:
J Postgrad Med
Ano de publicação:
2003
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS